Who owns SILENCE THERAPEUTICS PLC?
- Ticker: SLN
- CUSIP Number: 82686q101
Tip: Access positions for across all investors
Analyze quarterly positions in Silence Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Silence Therapeutics stock
Who bought or sold SILENCE THERAPEUTICS PLC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| TCG Crossover Management | 3.0M | $16M | 0% | Sep 2025 |
|
| Siren | 2.9M | $15M | 0% | Sep 2025 |
|
| Redmile Group | 2.2M | $11M | 0% | Sep 2025 |
|
| Lombard Odier Asset Management | 1.8M | $7.1M | 0% | Sep 2025 |
|
| Morgan Stanley | 1.2M | $7.0M | 100% | Jun 2025 |
|
| Vivo Capital | 1.1M | $5.7M | 0% | Sep 2025 |
|
| Nantahala Capital Management | 1.0M | $5.4M | 0% | Sep 2025 |
|
| Frazier Life Sciences Management | 970k | $5.0M | 0% | Sep 2025 |
|
| Nextech Invest | 952k | $4.9M | 0% | Sep 2025 |
|
| Ikarian Capital | 901k | $1.3M | 3% | Sep 2025 |
|
| Cantor Fitzgerald, L. P. | 801k | $4.2M | 2% | Sep 2025 |
|
| 5AM Venture Management | 476k | $2.5M | 0% | Sep 2025 |
|
| SG Americas Securities | 308k | $1.6M | 0% | Sep 2025 |
|
| UBS Group | 307k | $1.6M | 35% | Sep 2025 |
|
| Millennium Management | 299k | $1.5M | 50% | Sep 2025 |
|
| Boothbay Fund Management | 280k | $1.5M | 11% | Sep 2025 |
|
| M28 Capital Management | 185k | $961k | 0% | Sep 2025 |
|
| Hsbc Holdings | 173k | $909k | 0% | Sep 2025 |
|
| Bank Of Montreal | 146k | $846k | 100% | Jun 2025 |
|
| Marshall Wace | 83k | $432k | -53% | Sep 2025 |
|
| Two Sigma Investments | 63k | $328k | 7% | Sep 2025 |
|
| Woodline Partners | 63k | $324k | 0% | Sep 2025 |
|
| Advisor Group Holdings | 62k | $299k | -10% | Sep 2025 |
|
| BlackRock | 62k | $321k | -63% | Sep 2025 |
|
| Two Sigma Advisers | 43k | $221k | 8% | Sep 2025 |
|
| Geode Capital Management | 30k | $153k | 0% | Sep 2025 |
|
| Goldman Sachs Group | 23k | $118k | -7% | Sep 2025 |
|
| Citadel Advisors | 22k | $112k | 100% | Sep 2025 |
|
| Virtus Investment Advisers | 20k | $106k | 21% | Sep 2025 |
|
| ADAR1 Capital Management | 19k | $97k | 0% | Sep 2025 |
|
| Hrt Financial | 11k | $56k | 100% | Sep 2025 |
|
| EHP Funds | 11k | $55k | 100% | Sep 2025 |
|
| Cambridge Investment Research Advisors | 10k | $53k | 0% | Sep 2025 |
|
| GAMMA Investing | 9.9k | $52k | 19% | Sep 2025 |
|
| China Universal Asset Management | 8.2k | $43k | -13% | Sep 2025 |
|
| Jpmorgan Chase & Co | 7.8k | $40k | -78% | Sep 2025 |
|
| Wexford Capital | 7.7k | $40k | -72% | Sep 2025 |
|
| Barclays | 7.1k | $37k | 1% | Sep 2025 |
|
| Rhumbline Advisers | 5.9k | $30k | -5% | Sep 2025 |
|
| Acadian Asset Management | 4.2k | $21k | 100% | Sep 2025 |
|
| Jones Financial Companies, L.L | 2.5k | $14k | 0% | Sep 2025 |
|
| Tower Research Capital | 2.4k | $13k | 1% | Sep 2025 |
|
| Mirae Asset Global Investments | 1.8k | $9.4k | 0% | Sep 2025 |
|
| Parallel Advisors | 1.3k | $6.7k | 0% | Sep 2025 |
|
| Royal Bank of Canada | 1.1k | $6.1k | -54% | Sep 2025 |
|
| Gf Fund Management | 978.00 | $5.1k | -16% | Sep 2025 |
|
| Simplex Trading | 651.00 | $3.0k | -2% | Sep 2025 |
|
| Bnp Paribas Arbitrage, Snc | 600.00 | $3.1k | -14% | Sep 2025 |
|
| Steward Partners Investment Advisory | 100.00 | $519.000000 | 0% | Sep 2025 |
|
| Rockefeller Capital Management | 45.00 | $234.000000 | 100% | Sep 2025 |
|
| SBI Securities | 29.00 | $151.000100 | 4% | Sep 2025 |
|
| Principal Securities | 17.00 | $88.000500 | 0% | Sep 2025 |
|
Who sold out of Silence Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Jane Street | Jun 2025 | 61k | $352k |
| Saturn V Capital Management | Jun 2025 | 35k | $202k |
| Susquehanna International | Jun 2025 | 28k | $161k |
| Rathbones Brothers | Jun 2025 | 18k | $107k |
| Beacon Pointe Advisors | Jun 2025 | 12k | $67k |
| FNY Investment Advisers | Mar 2025 | 7.0k | $19k |